Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

F Pannuti; A Martoni; A R Di Marco; E Piana; F Saccani; G Becchi; G Mattioli; F Barbanti; G A Marra; W Persiani

doi:10.1016/0014-2964(79)90097-5

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/F86FC881

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F86FC881.svg?ark=w1%2F20260515%2FF86FC881)](https://nobleid.org/work/w1/20260515/F86FC881)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/F86FC881

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F86FC881.svg?ark=w1%2F20260515%2FF86FC881)](https://nobleid.org/work/w1/20260515/F86FC881)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work